Article Text

Download PDFPDF
CASE REPORT
Fatal measles pneumonitis during Hodgkin's lymphoma
  1. Benjamin Wyplosz1,
  2. Marion Lafarge2,
  3. Lélia Escaut1,
  4. Jean-Baptiste Stern1,3
  1. 1Assistance publique-hôpitaux de Paris, CHU Bicêtre, Service de Maladies Infectieuses et Tropicales, Le Kremlin-Bicêtre, France
  2. 2Assistance publique-hôpitaux de Paris, CHU Bichat-Claude Bernard, Réanimation Médicale, Paris, France
  3. 3Institut mutualiste Montsouris, Departement Thoracique, Paris, France
  1. Correspondence to Dr Benjamin Wyplosz, benjamin.wyplosz{at}bct.aphp.fr

Summary

The treatment of measles pneumonitis in immunocompromised adults is not established. We describe a patient with Hodgkin's lymphoma who developed acute pneumonia during a measles infection. On day 13, intravenous ribavirin and immunoglobulins were administrated. On day 18, the patient developed acute respiratory failure. An examination of transbronchial pulmonary biopsies showed Warthin-Finkeldey giant cells that are pathognomonic of measles pneumonitis. The patient died despite aggressive supportive care. Our case and a review of literature show that measles pneumonitis is routinely fatal in patients with cancer. We suggest that antiviral drugs should be considered as soon as the diagnosis has been established.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.